A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania
Sharpley, Ann L, Williams, Clare, Holder, Adele A, Godlewska, Beata R, Singh, Nisha, Shanyinde, Milensu, MacDonald, Orla, Cowen, Philip JJournal:
Psychopharmacology
DOI:
10.1007/s00213-020-05654-1
Date:
September, 2020
File:
PDF, 1001 KB
2020